| 周期 | 已完成事件 | 价格覆盖率 | 胜率 | 超额收益中位数 | 超额收益平均值 | 最差超额收益 |
|---|---|---|---|---|---|---|
| 5D | 5Developing evidence | 35.7% (5/14) | 20.0% (1/5) | -5.8% | -2.1% | -5.8% |
| 20D | 2小样本 | 18.2% (2/11) | 50.0% (1/2) | -4.5% | -4.5% | -11.1% |
| 60D | 2小样本 | 18.2% (2/11) | 0.0% (0/2) | -19.8% | -19.8% | -29.9% |
| 120D | 2小样本 | 18.2% (2/11) | 50.0% (1/2) | -11.7% | -11.7% | -43.2% |
公司研究
Kodiak Sciences Inc.
KOD · United States · 医疗保健
内部人信号
1 位内部人 · 2 个买入事件 · 净买入 $155.97m
美国 #170 · United States #170
为什么有这个信号?
评分构成
每条进度条表示其对当前分数的贡献;权重和公式未改变。
不同内部人是否在相近时间买入
买入金额相对公司规模和流动性的大小
参与买入的内部人职位权重
买入距离当前快照日期有多近
买入相对其他交易的清晰程度
哪些因素限制了当前分数?
- ⚠ 买方广度中等 · 少于 4 位不同申报人
- ⚠ 角色信息量贡献较低
- ✓ 近期有活动 · 最近买入 2026-09-29
角色贡献按美国模型的职位阶梯计算。
买入集中度
最大买方:667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP · 156.99m USD
合资格买入交易行总额(毛额):156.99m USD
顶部的 $ 合计为筛选的净买入;本模块使用合资格买入交易行的原币毛额,所以数值可能不同。当前“15 天买方广度”输入反映不同买方数量;金额集中度在此单独披露。
该数值是当前美国筛选规则下的排序,不是上涨概率、收益预测或买入建议。
关键买入报价(申报原币)
| 申报人 | 每单位价格 | 交易日期 |
|---|---|---|
| 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | 84.24–85.89 USD | Sep 29, 2026 |
| 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | 61.21–89.86 USD | Sep 28, 2026 |
模型细节
聚集度拆解(不改变总分)
- 15 天买方广度(计数)
- 1 位不同申报人
- 峰值时间窗口
- 2026-09-28 至 2026-09-29
- 当前广度输入
- 0.200(4 位及以上封顶)
- 买方独立性
- 尚未计量;关联方字段在各市场不可直接比较
申报记录显示什么?
- 🟢 近期合资格买入
667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP · 2.87m USD · 单价 84.24–85.89 USD · Sep 29, 2026 - 🟢 管理责任人买入
667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP · 154.12m USD · 单价 61.21–89.86 USD · Sep 28, 2026 - 🔴 6 条其他交易行未计入自主买入信号,其中 0 条为零价格交易
内部人交易与股价
180 天窗口内共 2 个买入日、82 条买入记录。另有 1 个卖出日、2 条卖出记录。
标记位于交易当日的收盘价上,表示内部人交易的时间,不代表其成交价格。“此后”比较的是当日收盘价与图中最新收盘价,是这家公司已经发生的情况,不是预测。
如果当时跟着买了
每一行从买入被公开当日或之后的第一个收盘价算起(读者最早能行动的时点),到上图最新收盘价为止。
| 公开日 | 内部人数 | 买这只股票,现在 | 买同交易所中位数股票,现在 | 差额 |
|---|---|---|---|---|
| 2026-09-30 | 1 | 1,053 +5.3% | 993 −0.7% | +60 +6.0 pts |
1 个披露日中,有 1 个跑赢了同交易所中位数股票。
按收盘价计算,未计交易成本、税费、股息和汇率变动。对照的是同一交易所内本站有价格数据的其他股票的中位数(此处 1091 只),不是指数。这是已经发生的情况,不是预测:就本站全部买入而言,典型差额接近于零。
内部人时间轴
只有一位内部人买入,共 2 次,最近一次(9 月 29 日)。那天收盘 91.12,最新收盘 99.87(+9.6%)。
点开每一项看它的意思。
●一次买入:点越大,买得越多
每个圆点是一位内部人在某一天的买入。点的面积按金额画:这里金额最大的一笔,点最大。把鼠标停在点上可以看到日期和金额。
×一次卖出
叉是一位内部人在某一天的卖出。卖出常常是为了缴税、把股权奖励变现或分散资产,所以它说明的东西比买入少。同一个人同一天既买又卖时,叉画在圆点旁边。合计数在下面“买入与卖出的比例”里。
蓝线:这只股票的股价,这半年 +116.4%
每天的收盘价,从 2026-04-21 的 46.14 到 2026-10-09 的 99.87。这条线没有刻度,只看高低:点落在线的低处,是低位买的;落在高处,就不是。
虚线:同一交易所的一般股票,这半年 −11.1%
取自同一交易所、本站有价格的另外 1230 只股票。每只都从窗口第一天起算涨跌,每天画出正中间那一只。它和蓝线从同一点出发,所以两条线之间的距离就是差距:这只股票 +116.4%,一般股票 −11.1%,领先 127.6 个百分点。它不是指数,也不是同行业之间的比较。
▂灰柱:全美国每周有多少家公司披露了买入
柱越高,那一周披露内部人买入的公司越多。
本公司每月买入的内部人数,近 12 个月
深色柱在上图的 180 天窗口之内。
谁在交易
| 内部人 | 职务 | 买入次数 | 卖出次数 | 买入金额 | 首次买入 | 此后股价 |
|---|---|---|---|---|---|---|
| BORGESON JOHN A. | 首席财务官 | — | 1 | — | — | — |
| 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | 董事会成员 | 2 | — | 157.0M USD | 2026-09-28 | +11.1% |
买入与卖出的比例
180 天窗口内内部人交易申报金额的占比。 卖出包括为缴税、行权或按预设计划进行的处置,这些并不能说明内部人的看法。这一比例描述的是已披露的情况,不是信号。
评分细节
排序值 = 100 × Σ(固定权重 × 0–1 规则化输入)
| 因子 | 权重 | 本公司输入 | 分数贡献 |
|---|---|---|---|
| 15 天买方广度(计数) | 35% | 0.200 | 7.0 |
| 合资格买入规模 | 25% | 0.990 | 24.8 |
| 角色信息量(反向) | 20% | 1.000 | 20.0 |
| 近期性 | 10% | 0.729 | 7.3 |
| 买卖确信度 | 10% | 0.993 | 9.9 |
这是当前规则的启发式排序,不是经校准的收益预测。它解释候选之间为什么排序不同;公开申报证据和数据限制见下方。
多空辩论
对这轮买入的两种解读
同一批申报,两种读法。每一条都是本站为该公司保存的事实并附上数字,只有当数字越过固定阈值时才会出现。两边都不是预测,这里也不判定哪一方获胜。
证据来自哪里
两类证据方向相反:内部人买入这一组有看多证据(买入规模大),而空头这一组看空(空头仓位高)。基本面、公司事件没有可用数据。
- 内部人买入本身看多买入规模大 看空只有一位买方核对过 6 项,未越过阈值 · 缺 1 项数据
- 股价与成交核对过 2 项,未越过阈值
- 空头看空空头仓位高核对过 1 项,未越过阈值
- 基本面缺 2 项数据
- 公司事件没有可用数据
看多理由 · 这轮买入有信息量
- 内部人在 180 天内净投入自有资金 $156.0M。
看空理由 · 应当打折扣
- 只有一位内部人买入。单人买入可能出于其个人财务安排,而不代表对公司的判断。
- 空头FINRA 公布的 2026-09-30 空头仓位为 9,376,012 股,相当于 1.8 天的日均成交量,占已发行的 62,849,457 股的 15%,较上一期减少 12%:其他投资者在相反一方持有不小的仓位。
还缺少哪些证据
- 这些买方中没有人拥有 5 次以上已完成的历史买入记录,因此无从衡量其过往准确度。
- 尚未取得公司市值,因此无法把买入金额表示为占公司规模或成交量的比例。
- 尚未取得该公司的盈利、利润率或现金流数据。业务是在改善还是恶化,需要查阅最近的年报和中期报告。
核对过但没有越过阈值:9 项
- 两边最近 180 天有 1 位内部人买入,此前 180 天为 1 位。至少翻倍且多 2 位才计入看多;此前至少 2 位且不少于本期才计入看空。
- 看空同一 180 天内内部人卖出 $1.0M,相当于买入金额的 0.65%;达到 25% 才计入看空。
- 两边最近一笔买入距今 19 天。不超过 14 天计入看多,达到 90 天计入看空。
- 看空股价六个月变动 +132%(三个月 +143%,一个月 +204%),现价比 52 周高点低 4.0%;下跌达到 20% 才计入看空。
- 看空三个月里股价变动 +143%,同行业(医疗保健,219 家)中位数变动 −12%,领先 155 个百分点;落后达到 20 个百分点才计入看空。
- 看空3 份买入申报均未勾选 Form 4 的 10b5-1 选项。
- 看空截至 2026-10-16 的最近 5 个交易日,这只股票场外成交里有 53% 是卖空;此前 60 个交易日是 61%。全市场中位数是 50%。这是成交量,不是仓位:做市商卖空后当天平掉也算在内,所以平常日子里全市场约一半的成交都是卖空。这里只作对照,不计入任何一方。
- 看多3 份买入申报中有 3 份写明了交易前后的持股数。对已有持股增加最多的一份,持股从 18,313,294 股增加到 19,121,134 股(+4.4%)。达到 +100% 才计入看多,不到 +1% 计入看空。
- 看空最近 180 天内没有内部人申报对这只股票建立对冲头寸。
多空两栏只整理已保存的事实,不影响内部人分数或排名,也不构成投资建议。
信号历史
最新留档分数
- 已留档快照
- 7
- 起始快照
- 2026-10-09
尚未积累满 30 个自然日的可比历史;不会补造此前分数。 这些是每次完整评分完成时保存的原始信号分数;它描述研究排序的变化,不是价格图表或收益表现。
为什么变化?
可比历史不足 30 天,暂时无法拆解变化。
信号分数历史
纵轴固定为 0–100;横轴按快照日期间隔绘制。
近期留档节点
- 63.1
- 69.6
- 69.4
- 69.3
- 69.0
查看全部留档分数
| 快照日期 | 信号分数 |
|---|---|
| 2026-10-09 | 63.1 |
| 2026-10-12 | 69.7 |
| 2026-10-13 | 69.6 |
| 2026-10-14 | 69.4 |
| 2026-10-15 | 69.3 |
| 2026-10-16 | 69.2 |
| 2026-10-18 | 69.0 |
行业背景
- 买入广度
- 4.1% (42 / 1,029 issuers)
- 行业排名
- #8 / 13
这是行业层面的研究背景,不影响 Insider Signal 或排名。
内部人历史结果
内部人申报公开后的历史表现。姓名下方同时显示英文职务解释和原始职称。
- 超额收益 = 股票收益 − 同期 S&P 500 ETF (SPY adjusted close) 收益。
- 胜率 = 超额收益为正的已完成事件 ÷ 全部已完成事件。
- 价格覆盖率 = 有效时点行情事件 ÷ 已成熟到该周期的事件。
- 收益从公开日当天或之后的首个共同交易日开始计算。
- 小样本规则:n<5 会透明展示,但不参与评分。
事件以 disclosure 为单位;同一公开日的关联申报可能共享相同收益路径,因此不一定统计独立。本研究增强数据不影响 insider score 或排名。
| 周期 | 已完成事件 | 价格覆盖率 | 胜率 | 超额收益中位数 | 超额收益平均值 | 最差超额收益 |
|---|---|---|---|---|---|---|
| 5D | 5Developing evidence | 35.7% (5/14) | 20.0% (1/5) | -5.8% | -2.1% | -5.8% |
| 20D | 2小样本 | 18.2% (2/11) | 50.0% (1/2) | -4.5% | -4.5% | -11.1% |
| 60D | 2小样本 | 18.2% (2/11) | 0.0% (0/2) | -19.8% | -19.8% | -29.9% |
| 120D | 2小样本 | 18.2% (2/11) | 50.0% (1/2) | -11.7% | -11.7% | -43.2% |
| 周期 | 已完成事件 | 价格覆盖率 | 胜率 | 超额收益中位数 | 超额收益平均值 | 最差超额收益 |
|---|---|---|---|---|---|---|
| 5D | 5Developing evidence | 35.7% (5/14) | 20.0% (1/5) | -5.8% | -2.1% | -5.8% |
| 20D | 2小样本 | 18.2% (2/11) | 50.0% (1/2) | -4.5% | -4.5% | -11.1% |
| 60D | 2小样本 | 18.2% (2/11) | 0.0% (0/2) | -19.8% | -19.8% | -29.9% |
| 120D | 2小样本 | 18.2% (2/11) | 50.0% (1/2) | -11.7% | -11.7% | -43.2% |
信号历史表现
按不可变排名快照计算;超额收益为股票收益减 SPY 收益。快照尚未达到前瞻周期时显示等待成熟,不影响美国评分。
| 周期 | 状态 | 结果 |
|---|---|---|
| 5D | 已完成 1 个 | -12.2% 中位数 |
| 20D | 等待成熟 | — |
| 60D | 等待成熟 | — |
| 120D | 等待成熟 | — |
市场背景
PRICE PERFORMANCE
VOLATILITY & LIQUIDITY
- 波动率
- 172.0%
- Beta
- —
- 日均成交额
- $160.0M
VALUATION
- 市值
- —
- 市盈率
- —
FUNDAMENTALS
- 利润率
- —
- ROE
- —
- 行业
- —
价格截至 11 Oct 2026,来源:OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance)。不影响分数或排名。
内部人买入价与最新收盘价
最近的收盘价已超过一周,不能代表现价。
内部人买入与市场成交规模
尚缺完整的价格和成交量历史。
行情覆盖: 0 个已核验交易日 · 最新交易日: — · 比例状态: 暂不可计算
成交额按收盘价 × 成交股数估算,并统一为货币主单位。仅比较已披露的合资格买入;可能存在披露延迟。合同或计划安排不等于自主买入。比例描述相对成交规模,不代表实际市场成交占比,不影响评分。
监管申报原文
- 内部人申报公告 · 披露日期 2026-09-30 · 交易日期 2026-09-29
- 内部人申报公告 · 披露日期 2026-09-30 · 交易日期 2026-09-28
- 内部人申报公告 · 披露日期 2026-09-30 · 交易日期 2026-09-28
展开全部 10 份申报
- 内部人申报公告 · 披露日期 2026-09-30 · 交易日期 2026-09-29
- 内部人申报公告 · 披露日期 2026-09-30 · 交易日期 2026-09-28
- 内部人申报公告 · 披露日期 2026-09-30 · 交易日期 2026-09-28
- 内部人申报公告 · 披露日期 2026-09-29 · 交易日期 2026-09-25
- 内部人申报公告 · 披露日期 2026-06-05 · 交易日期 2026-06-04
- 内部人申报公告 · 披露日期 2026-04-16 · 交易日期 2026-04-15
- 内部人申报公告 · 披露日期 2026-04-02 · 交易日期 2026-04-02
- 内部人申报公告 · 披露日期 2026-03-27 · 交易日期 2026-03-25
- 内部人申报公告 · 披露日期 2026-02-17 · 交易日期 2025-12-26
- 内部人申报公告 · 披露日期 2025-12-19 · 交易日期 2025-12-18
财报与内部人买入
| 业绩公告(8-K) | 之后 5 个交易日买入 | 之后 20 个交易日买入 | 此前 20 个交易日买方 |
|---|---|---|---|
| 2026-08-1316:00 ET · 收盘后首个交易日 2026-08-14 | 无 | 无 | 0 |
| 2026-05-0716:00 ET · 收盘后首个交易日 2026-05-08 | 无 | 无 | 0 |
| 2026-03-3116:54 ET · 收盘后首个交易日 2026-04-01 | 无 | 无 | 0 |
| 2025-11-1316:05 ET · 收盘后首个交易日 2025-11-14 | 无 | 无 | 0 |
业绩公告日期来自公司提交给 SEC 的 8-K(第 2.02 项,经营业绩);收盘后提交的,从下一个交易日起算。买入是 Form 4 申报的公开市场买入(代码 P),按交易日期计;Form 4 最多晚两个工作日提交,最近几天的数字还可能增加。这里只列事实,不影响分数或排名。
持有方式与交易计划背景
| 直接/间接持有 | Unavailable |
|---|---|
| 10b5-1 申报证据 | Unavailable |
| 证据获取时间 | 2026-10-18T21:07:10+00:00 |
这些是 accession 级别的申报字段。“Unavailable”表示尚未获取或解析,绝不会被推断为“No”,也不调整美国评分。
申报证据
以下为当前排名快照日期向前 365 天的底层国家申报记录。评分仅使用最近 180 天;较早的合资格股票买入保留供审计,但不进入当前分数。每张表保留原始字段并先显示前三行,其余记录可展开核验;其他交易不作为自主买入信号。
不计入评分的交易与分类
4 份合资格买入披露(84 条交易行)
展开全部 81 条剩余申报记录
| 交易日期 | 披露日期 | 申报人 | 职位 | 交易类型 | 标的 | 价格(原币主单位) | 报价币种 | 数量 | 申报金额(原币) | 来源 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-29 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 84.24 USD | USD | 619.0 | 52144.56 USD | 打开申报 |
| 2026-09-29 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 84.24 USD | USD | 10381.0 | 874495.44 USD | 打开申报 |
| 2026-09-29 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 85.4 USD | USD | 1195.0 | 102053.0 USD | 打开申报 |
| 2026-09-29 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 85.4 USD | USD | 20031.0 | 1710647.4000000001 USD | 打开申报 |
| 2026-09-29 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 85.89 USD | USD | 84.0 | 7214.76 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 86.72 USD | USD | 186.0 | 16129.92 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 86.72 USD | USD | 3114.0 | 270046.08 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 86.81 USD | USD | 957.0 | 83077.17 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 86.81 USD | USD | 16036.0 | 1392085.1600000001 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 86.94 USD | USD | 3790.0 | 329502.6 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 86.94 USD | USD | 63539.0 | 5524080.66 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 87.51 USD | USD | 4485.0 | 392482.35000000003 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 87.51 USD | USD | 75176.0 | 6578651.760000001 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 88.57 USD | USD | 5880.0 | 520791.6 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 88.57 USD | USD | 98561.0 | 8729547.77 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 88.65 USD | USD | 6428.0 | 569842.2000000001 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 88.65 USD | USD | 107772.0 | 9553987.8 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 89.6 USD | USD | 4932.0 | 441907.19999999995 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 89.6 USD | USD | 82673.0 | 7407500.8 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 89.86 USD | USD | 11729.0 | 1053967.94 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 89.86 USD | USD | 196608.0 | 17667194.88 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 81.02 USD | USD | 1024.0 | 82964.48 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 81.02 USD | USD | 17159.0 | 1390222.18 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 81.2 USD | USD | 338.0 | 27445.600000000002 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 81.2 USD | USD | 5654.0 | 459104.8 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 81.31 USD | USD | 1044.0 | 84887.64 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 81.31 USD | USD | 17490.0 | 1422111.9000000001 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 80.52 USD | USD | 1027.0 | 82694.04 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 80.52 USD | USD | 61.0 | 4911.719999999999 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 80.23 USD | USD | 6783.0 | 544200.0900000001 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 80.23 USD | USD | 404.0 | 32412.920000000002 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 79.71 USD | USD | 14827.0 | 1181860.17 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 79.71 USD | USD | 884.0 | 70463.64 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 79.63 USD | USD | 283.0 | 22535.289999999997 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 79.63 USD | USD | 17.0 | 1353.71 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 79.4 USD | USD | 8956.0 | 711106.4 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 79.4 USD | USD | 534.0 | 42399.600000000006 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 85.97 USD | USD | 38932.0 | 3346984.04 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 85.97 USD | USD | 2322.0 | 199622.34 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 84.85 USD | USD | 109842.0 | 9320093.7 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 84.85 USD | USD | 6553.0 | 556022.0499999999 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 83.95 USD | USD | 123888.0 | 10400397.6 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 83.95 USD | USD | 7390.0 | 620390.5 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 83.16 USD | USD | 19554.0 | 1626110.64 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 83.16 USD | USD | 1167.0 | 97047.72 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 82.68 USD | USD | 1699.0 | 140473.32 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 82.68 USD | USD | 101.0 | 8350.68 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 81.92 USD | USD | 651.0 | 53329.92 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 81.92 USD | USD | 39.0 | 3194.88 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 81.82 USD | USD | 1672.0 | 136803.03999999998 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 81.82 USD | USD | 28028.0 | 2293250.96 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 61.21 USD | USD | 856.0 | 52395.76 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 62.96 USD | USD | 4067.0 | 256058.32 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 61.63 USD | USD | 2666.0 | 164305.58000000002 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 61.63 USD | USD | 44690.0 | 2754244.7 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 73.97 USD | USD | 4577.0 | 338560.69 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 73.97 USD | USD | 76723.0 | 5675200.31 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 75.52 USD | USD | 1924.0 | 145300.47999999998 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 75.52 USD | USD | 32261.0 | 2436350.7199999997 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 76.35 USD | USD | 3681.0 | 281044.35 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 76.35 USD | USD | 61700.0 | 4710795.0 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 77.43 USD | USD | 2884.0 | 223308.12000000002 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 77.43 USD | USD | 48350.0 | 3743740.5000000005 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 78.57 USD | USD | 2969.0 | 233274.33 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 78.57 USD | USD | 49771.0 | 3910507.4699999997 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 64.43 USD | USD | 479.0 | 30861.970000000005 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 72.39 USD | USD | 278978.0 | 20195217.42 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 73.08 USD | USD | 4696.0 | 343183.68 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 73.08 USD | USD | 78726.0 | 5753296.08 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 64.43 USD | USD | 8021.0 | 516793.03 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 62.96 USD | USD | 243.0 | 15299.28 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 72.39 USD | USD | 16641.0 | 1204641.99 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 71.48 USD | USD | 17698.0 | 1265053.04 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 71.48 USD | USD | 1056.0 | 75482.88 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 68.96 USD | USD | 39066.0 | 2693991.36 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 68.96 USD | USD | 2331.0 | 160745.75999999998 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 68.37 USD | USD | 2585.0 | 176736.45 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 68.37 USD | USD | 154.0 | 10528.980000000001 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 67.1 USD | USD | 5382.0 | 361132.19999999995 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 67.1 USD | USD | 321.0 | 21539.1 USD | 打开申报 |
| 2026-09-28 | 2026-09-30 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Director,TenPercentOwner | Open market purchase | Common Stock | 61.21 USD | USD | 14344.0 | 877996.24 USD | 打开申报 |
显示 84 of 84 条原始数据,来自当前 365天研究窗口。 价格与申报金额保留申报币种及其主单位(例如英国 pence 在解析时已换为 GBP)。页面顶部的 $ 汇总则单独按 FX 快照规范化,仅用于研究排序,不是交易日换汇金额。
其他已披露交易 · 不计入评分
展开 14 条其他交易
展开全部 11 条剩余申报记录
| 交易日期 | 披露日期 | 申报人 | 职位 | 交易类型 | 标的 | 价格(原币主单位) | 报价币种 | 数量 | 申报金额(原币) | 来源 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-04 | 2026-06-05 | BORGESON JOHN A. | Chief Financial Officer | Exercise of derivative security | Common Stock | 1.04 USD | USD | 30000.0 | 31200.0 USD | 打开申报 |
| 2026-06-04 | 2026-06-05 | BORGESON JOHN A. | Chief Financial Officer | Open market sale | Common Stock | 34.01 USD | USD | 25896.0 | 880722.96 USD | 打开申报 |
| 2026-04-15 | 2026-04-16 | BORGESON JOHN A. | Chief Financial Officer | Exercise of derivative security | Common Stock | 1.04 USD | USD | 28614.0 | 29758.56 USD | 打开申报 |
| 2026-04-02 | 2026-04-02 | BORGESON JOHN A. | Chief Financial Officer | Exercise of derivative security | Common Stock | 1.04 USD | USD | 30000.0 | 31200.0 USD | 打开申报 |
| 2026-04-02 | 2026-04-02 | BORGESON JOHN A. | Chief Financial Officer | Open market sale | Common Stock | 39.14 USD | USD | 12692.0 | 496764.88 USD | 打开申报 |
| 2026-04-02 | 2026-04-02 | BORGESON JOHN A. | Chief Financial Officer | Open market sale | Common Stock | 40.29 USD | USD | 12477.0 | 502698.33 USD | 打开申报 |
| 2026-04-02 | 2026-04-02 | BORGESON JOHN A. | Chief Financial Officer | Open market sale | Common Stock | 40.88 USD | USD | 4231.0 | 172963.28 USD | 打开申报 |
| 2026-04-02 | 2026-04-02 | BORGESON JOHN A. | Chief Financial Officer | Open market sale | Common Stock | 41.77 USD | USD | 600.0 | 25062.000000000004 USD | 打开申报 |
| 2026-09-25 | 2026-09-29 | PERLROTH VICTOR | Chairman and CEO | Exercise of derivative security | Common Stock | 2.49 USD | USD | 365840.0 | 910941.6000000001 USD | 打开申报 |
| 2026-09-25 | 2026-09-29 | PERLROTH VICTOR | Chairman and CEO | Exercise of derivative security | Common Stock | 5.38 USD | USD | 600000.0 | 3228000.0 USD | 打开申报 |
| 2026-09-25 | 2026-09-29 | PERLROTH VICTOR | Chairman and CEO | Exercise of derivative security | Common Stock | 3.95 USD | USD | 314684.0 | 1243001.8 USD | 打开申报 |
显示 14 of 14 条原始数据,来自当前 365天研究窗口。 价格与申报金额保留申报币种及其主单位(例如英国 pence 在解析时已换为 GBP)。页面顶部的 $ 汇总则单独按 FX 快照规范化,仅用于研究排序,不是交易日换汇金额。
快照与身份
- 快照日期
- 2026-10-18
- 代码
- KOD
- ISIN
- —
- 行业
- 医疗保健
- 细分行业
- —
公司 logo 由 Parqet 提供